0001209191-17-028749.txt : 20170428 0001209191-17-028749.hdr.sgml : 20170428 20170428164457 ACCESSION NUMBER: 0001209191-17-028749 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170428 FILED AS OF DATE: 20170428 DATE AS OF CHANGE: 20170428 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEIDEN JEFFREY M CENTRAL INDEX KEY: 0001242825 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 17796410 MAIL ADDRESS: STREET 1: 40 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-28 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001242825 LEIDEN JEFFREY M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 1 1 0 0 CEO & President Common Stock 2017-04-28 4 M 0 88507 29.98 A 395152 D Common Stock 2017-04-28 4 M 0 1527 34.39 A 396679 D Common Stock 2017-04-28 4 M 0 20000 34.24 A 416679 D Common Stock 2017-04-28 4 M 0 30000 34.05 A 446679 D Common Stock 2017-04-28 4 S 0 157200 119.50 D 289479 D Common Stock 440 I 401k Stock Option (Right to Buy) 29.98 2017-04-28 4 M 0 88507 0.00 D 2021-12-13 Common Stock 88507 124601 D Stock Option (Right to Buy) 34.39 2017-04-28 4 M 0 1527 0.00 D 2020-12-14 Common Stock 1527 0 D Stock Option (Right to Buy) 34.24 2017-04-28 4 M 0 20000 0.00 D 2020-05-31 Common Stock 20000 0 D Stock Option (Right to Buy) 34.05 2017-04-28 4 M 0 30000 0.00 D 2019-07-05 Common Stock 30000 0 D Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1. Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $119.50 (range $119.50 to $119.60). Fully vested. Omar White, Attorney-In-Fact 2017-04-28